Chief Strategy Officer, AdvaMed
Andrew Fish is Chief Strategy Officer of AdvaMed, the leading trade association advancing medical technology in the U.S. and around the world. As chief strategy officer, Mr. Fish leads the association’s strategic planning, manages AdvaMed's global, regulatory, and payment departments, and coordinates the development and operations of AdvaMed’s membership divisions and sectors.
Mr. Fish formerly served as Executive Director of AdvaMedDx, AdvaMed’s diagnostics division that operates as the U.S. trade association representing leading manufacturers of medical diagnostic tests. Mr. Fish joined AdvaMedDx upon its founding in 2010 and led the development of AdvaMedDx into a globally influential advocacy organization.
Mr. Fish has extensive experience navigating the complex intersections of business, science, media, law, regulation, and politics.
Prior to joining AdvaMedDx, Mr. Fish was Senior Vice President of Legal and Government Affairs, General Counsel, and Secretary for the Consumer Healthcare Products Association (CHPA), representing manufacturers of non-prescription medicines. Mr. Fish also led the American Cancer Society’s federal lobbying team as the Senior Director of Federal Government Relations.
Earlier in Mr. Fish’s career, he served in the Senate-confirmed post of Assistant Secretary of Agriculture for Congressional and Intergovernmental Affairs. Prior to that position, he worked twice for the U.S. Senate Agriculture Committee, first as a professional staff member and later as deputy chief counsel.
In his legal practice, Mr. Fish focused on biotechnology regulation, as well as on a wide range of food, drug and agriculture issues.
Mr. Fish is a graduate of Yale University and Stanford Law School.